Literature DB >> 23300173

A combination treatment approach and cord blood stem cell transplant for blastic plasmacytoid dendritic cell neoplasm.

Muthalagu Ramanathan, Jan Cerny, Hongbo Yu, Bruce A Woda, Rajneesh Nath.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23300173      PMCID： PMC3659934          DOI： 10.3324/haematol.2012.080051

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  5 in total

1.  Fludarabine, melphalan, thiotepa and anti-thymocyte globulin conditioning for unrelated cord blood transplant.

Authors:  Stefan O Ciurea; Rima M Saliba; Nelson Hamerschlak; Amado J Karduss Aurueta; Roland Bassett; Marcelo Fernandez-Vina; Demetrios Petropoulos; Laura L Worth; Ka Wah Chan; Daniel R Couriel; Gabriela Rondon; Manish Sharma; Muzaffar Qazilbash; Roy B Jones; Partow Kebriaei; John McMannis; Chitra M Hosing; Yago Nieto; Richard E Champlin; Elizabeth J Shpall; Marcos de Lima
Journal:  Leuk Lymphoma       Date:  2012-01-03

2.  Phase II study of SMILE chemotherapy for newly diagnosed stage IV, relapsed, or refractory extranodal natural killer (NK)/T-cell lymphoma, nasal type: the NK-Cell Tumor Study Group study.

Authors:  Motoko Yamaguchi; Yok-Lam Kwong; Won Seog Kim; Yoshinobu Maeda; Chizuko Hashimoto; Cheolwon Suh; Koji Izutsu; Fumihiro Ishida; Yasushi Isobe; Eisaburo Sueoka; Junji Suzumiya; Takao Kodama; Hiroshi Kimura; Rie Hyo; Shigeo Nakamura; Kazuo Oshimi; Ritsuro Suzuki
Journal:  J Clin Oncol       Date:  2011-10-11       Impact factor: 44.544

3.  TCL1 expression in plasmacytoid dendritic cells (DC2s) and the related CD4+ CD56+ blastic tumors of skin.

Authors:  Marco Herling; Michael A Teitell; Rhine R Shen; L Jeffrey Medeiros; Dan Jones
Journal:  Blood       Date:  2003-02-06       Impact factor: 22.113

4.  Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation: an Italian multicenter study.

Authors:  Livio Pagano; Caterina Giovanna Valentini; Alessandro Pulsoni; Simona Fisogni; Paola Carluccio; Francesco Mannelli; Monia Lunghi; Gianmatteo Pica; Francesco Onida; Chiara Cattaneo; Pier Paolo Piccaluga; Eros Di Bona; Elisabetta Todisco; Pellegrino Musto; Antonio Spadea; Alfonso D'Arco; Stefano Pileri; Giuseppe Leone; Sergio Amadori; Fabio Facchetti
Journal:  Haematologica       Date:  2012-10-12       Impact factor: 9.941

Review 5.  Hematopoietic stem-cell transplantation using umbilical-cord blood.

Authors:  Yossi Cohena; Arnon Nagler
Journal:  Leuk Lymphoma       Date:  2003-08
  5 in total
  5 in total

Review 1.  Transplantation in rare lymphoproliferative and histiocytic disorders.

Authors:  Alexis Cruz-Chacon; John Mathews; Ernesto Ayala
Journal:  Cancer Control       Date:  2014-10       Impact factor: 3.302

2.  In vivo and in vitro sensitivity of blastic plasmacytoid dendritic cell neoplasm to SL-401, an interleukin-3 receptor targeted biologic agent.

Authors:  Fanny Angelot-Delettre; Anne Roggy; Arthur E Frankel; Baptiste Lamarthee; Estelle Seilles; Sabeha Biichle; Bernard Royer; Eric Deconinck; Eric K Rowinsky; Christopher Brooks; Valerie Bardet; Blandine Benet; Hind Bennani; Zehaira Benseddik; Agathe Debliquis; Daniel Lusina; Mikael Roussel; Françoise Solly; Michel Ticchioni; Philippe Saas; Francine Garnache-Ottou
Journal:  Haematologica       Date:  2014-11-07       Impact factor: 9.941

3.  Reply to "A combination treatment approach and cord blood stem cell transplant for blastic plasmacytoid dendritic cell neoplasm" and to "A low-grade B-cell lymphoma with prolymphocytic/paraimmunoblastic proliferation and IRF4 rearrangement" dendritic cell leukemia.

Authors:  Livio Pagano; Caterina Giovanna Valentini; Fabio Facchetti
Journal:  Haematologica       Date:  2013-03       Impact factor: 9.941

4.  Haploinsufficiency for NR3C1, the gene encoding the glucocorticoid receptor, in blastic plasmacytoid dendritic cell neoplasms.

Authors:  Anouk Emadali; Neda Hoghoughi; Samuel Duley; Azadeh Hajmirza; Els Verhoeyen; Francois-Loic Cosset; Philippe Bertrand; Christophe Roumier; Anne Roggy; Céline Suchaud-Martin; Martine Chauvet; Sarah Bertrand; Sieme Hamaidia; Sophie Rousseaux; Véronique Josserand; Julie Charles; Isabelle Templier; Takahiro Maeda; Juliana Bruder-Costa; Laurence Chaperot; Joel Plumas; Marie-Christine Jacob; Thierry Bonnefoix; Sophie Park; Remy Gressin; Cornelis P Tensen; Cristina Mecucci; Elizabeth Macintyre; Dominique Leroux; Elisabeth Brambilla; Florence Nguyen-Khac; Isabelle Luquet; Dominique Penther; Christian Bastard; Fabrice Jardin; Christine Lefebvre; Francine Garnache; Mary B Callanan
Journal:  Blood       Date:  2016-04-08       Impact factor: 22.113

5.  Blastic plasmacytoid dendritic cell leukemia successfully treated by autologous hematopoietic stem cell transplantation to a remission of 48-month duration.

Authors:  Deniz Goren Sahin; Olga Meltem Akay; Hava Usküdar Teke; Neslihan Andıc; Eren Gunduz; Zafer Gulbas
Journal:  Case Rep Hematol       Date:  2013-12-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.